About UMM Biorepository The University of Maryland School of Medicine established a biorepository intending to provide the resources and support for large-scale studies. They aim to empower basic and clinical researchers to make discoveries in genomics and ‘omics’ sciences and translate these discoveries to more effective diagnostics and therapeutics. Currently, the UMM Biorepository has data of 28000+ […]
The Mouse Biology Program (MBP) of the University of California, Davis (UCD) is the largest academic program in the world. MBP is a member of the NIH-funded Mutant Mouse Resource and Research Centers (MMRRC). The network collects and characterizes gene-modified and genetic knockout lab mice, and makes them available to 800 researchers at over 400 […]
The Victorian Cancer Biobank (VCB) is a crucial part of the medical research landscape supporting researchers throughout Australia and around the world with the aim of delivering better clinical outcomes to people suffering from cancer. VCB is a consortium of five major health precincts in Victoria (26 hospitals within the network) including Austin Health, Eastern […]
Currently, biobanks at the University Hospital Basel are not centralized. Storage locations are distributed over organizational units, which partly are about to be centrally managed. Biobank inventory management is currently performed in disconnected systems, including Excel lists. There is currently no integrated biobank management software solution in place. To achieve a professional biobank software solution […]
The Winship Cancer Institute Clinical Trial office (CTO) conducts high-quality clinical trials involving cancer patients. It conducts over 250 clinical trials enrolling roughly 800 patients per year. In May 2016, they adopted OpenSpecimen as their biobanking LIMS to manage their biospecimens due to its highly configurable features including REST APIs to integrate with . Refer to […]
Research in precision medicine requires a continuous supply of high-quality biospecimens. But as the saying goes- “Garbage in garbage out”, meaningful conclusions from the studies can only be drawn when the researchers are assured that the materials used in their research were of good quality. A survey(1) conducted by the National Cancer Institute (NCI) funded cancer […]
Customer Speak “We were looking for a robust and structured system that is able to manage our biobank in a constructive way. We chose OpenSpecimen as the system was able to be customized to our specific needs and the developers, Krishagni were dedicated to biobanking and had a vast depth of experience that we could […]
The short answer is Yes. However, it is important to note that the software itself cannot be compliant. Rather, it is the implementation and use of software that determines compliance. It is achieved only when a study has the procedures, policies, documentation, training, and validation that meets Part-11 requirements. An FDA auditor will review all […]
This case study describes the adoption of OpenSpecimen at one of the biggest biobanks in gastroenterology (GI) cancer in an academic center in Pittsburgh. Prior to OpenSpecimen, they used an in-house system to store clinical and specimen data. However, it had several shortcomings which were severely impeding their ability to find specimens of research interest. […]
Following is a poster presented by the Victorian Cancer Biobank team on using OpenSpecimen for ‘Improving interoperability and quality of data’ at the ABNA 2019 conference. VCB has collected more than 600,000 biospecimens from a broad range of tumours, and approximately 423,000 biospecimens are currently in our inventory. OpenSpecimen was implemented as the biobank information […]
